1.
Lin Y, Chen X, Lin Z, Yan W. Dexmedetomidine alleviates high glucose-induced podocyte damage by inhibiting EDA2R. Trop. J. Pharm Res [Internet]. 2022 Oct. 13 [cited 2026 Sep. 6];21(9):1885-91. Available from: https://www.ajol.info/index.php/tjpr/article/view/234007